ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

644
Analysis
Health Care • South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
•26 Dec 2016 16:13

Free Cash Flow Remains King in Weeding Out the Winners and Losers

The Korean Stock Market remains surprisingly fundamental driven and free cash flow remains a fundamental factor that could help investors to weed...

Logo
428 Views
Share
•23 Dec 2016 07:38

Weeding Out the Chaff for Portfolio Outperformance in 2017

Investors prefer companies that can consistently grow their sales and profits, at reasonable valuations. In this report, we selected 72 companies...

Logo
291 Views
Share
•08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Logo
4.1k Views
Share
•30 Nov 2016 15:45

Korea Stock Market Monthly Recap #8 - (November 2016)

November was dominated by politics driving the capital markets both in Korea and the US. The Choi Soon Shil scandal rocked Korean politics and put...

Logo
282 Views
Share
bullish•SillaJen Inc
•29 Nov 2016 05:36

SillaJen IPO Part 5 - Revenue & Valuation Estimates with Pexa-Vec's First Commercialization Year

We need to examine the size of SillaJen's expected sales in 2020, which is the reference year for its entire valuation. With an assumption that...

Logo
448 Views
Share
x